Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-30

FDA Approved: DELSTRIGO — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved Delstrigo, a fixed-dose combination tablet containing doravirine, lamivudine, and tenofovir disoproxil fumarate, as a complete regimen for trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DELSTRIGO (DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE)

Snippet

ORIG AP for DELSTRIGO (DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE)